Frank Ruffo

Insider Reports History

Location
Malvern, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Ruffo:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Financial Officer Common Stock 201,883 $211,977 $1.05 10 Mar 2022 Direct

Insider Reports Filed by Frank Ruffo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 10 Mar 2022 1 -$199,335 4 Chief Financial Officer 14 Mar 2022, 16:56
ACRS Aclaris Therapeutics, Inc. 01 Mar 2022 8 $0 4 Chief Financial Officer 03 Mar 2022, 17:08
ACRS Aclaris Therapeutics, Inc. 09 Feb 2022 1 -$17,568 4 Chief Financial Officer 11 Feb 2022, 15:18
ACRS Aclaris Therapeutics, Inc. 01 Feb 2022 2 $0 4 Chief Financial Officer 03 Feb 2022, 15:46
ACRS Aclaris Therapeutics, Inc. 01 Jun 2021 4 -$325,383 4 Chief Financial Officer 02 Jun 2021, 21:43